Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Tizanidine class
Use: Fatigue
Bupropion class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
MOA: Immune modulator, exact mechanism not known.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Baclofen class
Use: treatment of spasticity
Off line agent used in the treatment of acute attacks
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dose: IV infusion every 3 months
Use: For pts who do not respond to corticosteroids during acute attacks
Tricyclic class
Use: Fatigue, cognitive impairment (long acting agent)
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
First line RRMS agent injected SC daily
Fingolimod class
Axathioprine class
Mycophenolate class
Prednisone class
Dose: IM weekly
Modafinil class
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Alemtizumab class
Methylprednisone class
Excreted by kidney: contraindicated in moderate to severe renal failure
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Carbamazepine class
Second line agent MOA: monoclonal Ab
Rituximab class
Dose: 1 gram/day IV for 3-5 days
Use: Depression. Also helps with pain
First line drugs for disease modification
Natalizumab class
Second line agent: RRMS. Reduced relapses & progression of disability
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Use: Depression. Also helps with fatigue
Daclizumab class
Methotrexate class
Plasmapheresis class
MOA: Anti-organ rejection drug
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Second line agent given IV monthy
Mitoxantrone class
Venlafaxine class
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
MOA: Immunomodulator/antineoplastic
Dose: Oral. In extreme cases intrathecal
Dose: 1250 mg/day PO for 3-5 days
Duloxetine class
IFN beta 1-a (Rebif) class
MOA: Purine analog
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Methylphenidate class
MOA: alkylating agent
Cyclophosphamide class
Dose: Oral daily (first PO MS drug)
IFN beta 1-a (Avonex) class
Dose: SC injection every other day
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Glatiramer acetate class
Use: pain and paroxysmal disorders
Dalfampridine class
IFN beta 1-b (Betaseron) class
Dose: SC injection 2-3 times weekly
Gabapentin class
MOA: Antimetabolite and antifolate
Second line agent for RRMS that produces reduction in progression of disabilty

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created Oct 18, 2011ReportNominate
Tags:agent, multiple